Vaccine News and Research

Latest Vaccine News and Research

Secondhand smoke may have different effects on men and women, Amish community research finds

New research at the University of Maryland School of Medicine has found that secondhand smoke tends to have somewhat different effects on men and women.

5 May 2017

Computational analysis highlights potential economic burden of Zika outbreak in the U.S.

Even a relatively mild Zika outbreak in the United States could cost more than $183 million in medical costs and productivity losses, suggests a computational analysis led by Johns Hopkins Bloomberg School of Public Health researchers, while a more severe one could result in $1.2 billion or more in medical costs and productivity losses.

3 May 2017

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Sarcomas- cancers of the connective tissues like muscles, joints, fat and bone - come in dozens of subtypes. Clinical trial results have been mixed when treating these diverse tumors with immunotherapy, a targeted therapeutic strategy that has success in other cancers.

3 May 2017

Mayo Clinic scientists develop novel nanoparticle to shrink tumors, prevent breast cancer recurrence

A Mayo Clinic research team has developed a new type of cancer-fighting nanoparticle aimed at shrinking breast cancer tumors, while also preventing recurrence of the disease.

2 May 2017

Scientists rewire mouse stem cells to fight inflammation caused by arthritis

Using new gene-editing technology, researchers have rewired mouse stem cells to fight inflammation caused by arthritis and other chronic conditions.

28 Apr 2017

Early blood test can predict vaccine immunogenicity

Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect.

26 Apr 2017

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

The World Health Organization Regional Office for Africa announced today that Ghana, Kenya, and Malawi will take part in a WHO-coordinated malaria vaccine implementation programme (MVIP) that will make the world’s first malaria vaccine available in selected areas, beginning in 2018.

26 Apr 2017

Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

Patients who expressed the tumor antigen NY-ESO-1 had more aggressive cancers and were more likely to die early from their disease, according to a large study conducted by Roswell Park Cancer Institute researchers and published online ahead of print in the journal Gynecologic Oncology.

26 Apr 2017

UC Santa Cruz researcher identifies major gaps that must be filled in to control Lyme disease

Scientists have built a large body of knowledge about Lyme disease over the past 40 years, yet controversies remain and the number of cases continues to rise.

25 Apr 2017

Synthetic scaffold loaded with cancer-fighting T cells effectively shrinks solid tumors

Cellular therapy hasn't had much success in fighting solid tumors, partly because it's been difficult to deliver anti-cancer T cells to the tumors.

25 Apr 2017

UTSW researchers develop new nanoparticle vaccine immunotherapy that targets multiple tumor types

Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types.

24 Apr 2017

Pregnant women’s financial strain linked to low-birth-weight infants

A financially strapped pregnant woman's worries about the arrival and care of her little one could contribute to birth of a smaller, medically vulnerable infant, a new study suggests.

24 Apr 2017

WHO drive for increased efforts to prevent malaria

WHO drive for accelerated development efforts to save lives, An event in Nairobi on the eve of World Malaria Day, sees the World Health Organization push for increased efforts to save lives through malaria prevention.

24 Apr 2017

Tiny silica 'cages' could help store and transport vaccines without refrigeration

Vaccines and antibodies could be transported and stored without refrigeration by capturing them in tiny silica 'cages', a discovery which could make getting vital medicines to remote or dangerous places much easier, cheaper and safer.

24 Apr 2017

UC San Diego Amazonian Center to receive NIH funding for malaria research

The Amazonian Center of Excellence for Malaria Research, headed by Joseph Vinetz, MD, professor of medicine and tropical disease specialist at University of California San Diego School of Medicine, will receive up to approximately $8.3 million over seven years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

21 Apr 2017

Research findings pave way for more efficient, protective influenza vaccines

New findings challenge the traditional policy of replacing old strains in existing human influenza vaccines with recent variants with only minimal changes.

21 Apr 2017

NIH announces 2017 ICEMR awards for 7 international malaria research centers

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $9 million in first-year funding, subject to availability, for seven malaria research centers around the world.

21 Apr 2017

WHO and partners roll-out vaccine campaigns to contain outbreak of meningitis C in Nigeria

A vaccination campaign is underway in Nigeria to contain an outbreak of meningitis C, a strain of meningitis which first emerged in the country in 2013. Since the beginning of this year, the country has reported 4637 suspected cases and 489 deaths across five states.

21 Apr 2017

Novel test can rapidly diagnose flu in patients with severe respiratory illnesses

Doctors and researchers in Southampton have developed a novel way of using a swab test which can rapidly diagnose flu and other viral infections in patients with severe respiratory conditions – resulting in shorter courses of antibiotics and less time in hospital.

20 Apr 2017

Researchers report new evidence that defective HIV proviruses distract immune system

Researchers at Johns Hopkins and George Washington universities report new evidence that proteins created by defective forms of HIV long previously believed to be harmless actually interact with our immune systems and are actively monitored by a specific type of immune cell, called cytotoxic T cells.

19 Apr 2017

Vaccine News and Research

Latest Vaccine News and Research

Secondhand smoke may have different effects on men and women, Amish community research finds

Computational analysis highlights potential economic burden of Zika outbreak in the U.S.

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Mayo Clinic scientists develop novel nanoparticle to shrink tumors, prevent breast cancer recurrence

Scientists rewire mouse stem cells to fight inflammation caused by arthritis

Early blood test can predict vaccine immunogenicity

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

UC Santa Cruz researcher identifies major gaps that must be filled in to control Lyme disease

Synthetic scaffold loaded with cancer-fighting T cells effectively shrinks solid tumors

UTSW researchers develop new nanoparticle vaccine immunotherapy that targets multiple tumor types

Pregnant women’s financial strain linked to low-birth-weight infants

WHO drive for increased efforts to prevent malaria

Tiny silica 'cages' could help store and transport vaccines without refrigeration

UC San Diego Amazonian Center to receive NIH funding for malaria research

Research findings pave way for more efficient, protective influenza vaccines

NIH announces 2017 ICEMR awards for 7 international malaria research centers

WHO and partners roll-out vaccine campaigns to contain outbreak of meningitis C in Nigeria

Novel test can rapidly diagnose flu in patients with severe respiratory illnesses

Researchers report new evidence that defective HIV proviruses distract immune system

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in